XPH vs. PPH
Compare and contrast key facts about SPDR S&P Pharmaceuticals ETF (XPH) and VanEck Vectors Pharmaceutical ETF (PPH).
XPH and PPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XPH is a passively managed fund by State Street that tracks the performance of the S&P Pharmaceuticals Select Industry Index. It was launched on Jun 19, 2006. PPH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Pharmaceutical 25 Index. It was launched on Dec 20, 2011. Both XPH and PPH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XPH or PPH.
Performance
XPH vs. PPH - Performance Comparison
Returns By Period
In the year-to-date period, XPH achieves a 10.70% return, which is significantly higher than PPH's 9.00% return. Over the past 10 years, XPH has underperformed PPH with an annualized return of 0.07%, while PPH has yielded a comparatively higher 4.96% annualized return.
XPH
10.70%
-2.44%
11.37%
26.54%
3.80%
0.07%
PPH
9.00%
-6.61%
-2.86%
14.42%
9.32%
4.96%
Key characteristics
| XPH | PPH | |
|---|---|---|
| Sharpe Ratio | 1.52 | 1.34 |
| Sortino Ratio | 2.22 | 1.91 |
| Omega Ratio | 1.26 | 1.24 |
| Calmar Ratio | 0.68 | 1.16 |
| Martin Ratio | 3.93 | 4.29 |
| Ulcer Index | 6.47% | 3.38% |
| Daily Std Dev | 16.77% | 10.80% |
| Max Drawdown | -48.03% | -46.49% |
| Current Drawdown | -20.89% | -11.68% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XPH vs. PPH - Expense Ratio Comparison
XPH has a 0.35% expense ratio, which is lower than PPH's 0.36% expense ratio.
Correlation
The correlation between XPH and PPH is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
XPH vs. PPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XPH vs. PPH - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 1.53%, less than PPH's 1.84% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 1.53% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% | 5.55% | 2.06% |
PPH VanEck Vectors Pharmaceutical ETF | 1.84% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% | 1.71% | 2.03% |
Drawdowns
XPH vs. PPH - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, roughly equal to the maximum PPH drawdown of -46.49%. Use the drawdown chart below to compare losses from any high point for XPH and PPH. For additional features, visit the drawdowns tool.
Volatility
XPH vs. PPH - Volatility Comparison
SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 5.29% compared to VanEck Vectors Pharmaceutical ETF (PPH) at 3.94%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.